Hutchison China Meditech Limited
Sulfatinib Phase II Study in 2nd Line BTC in China - Seite 4
CONTACTS
Investor Enquiries | ||||
Christian Hogg, CEO | +852 2121 8200 | |||
International Media Enquiries | ||||
Anthony Carlisle, Citigate Dewe Rogerson |
+44 7973 611 888 (Mobile) | anthony.carlisle@cdrconsultancy.co.uk | ||
U.S. Based Media Enquiries | ||||
Brad Miles, BMC Communications | +1 (917) 570 7340 (Mobile) | bmiles@bmccommunications.com | ||
Susan Duffy, BMC Communications | +1 (917) 499 8887 (Mobile) | sduffy@bmccommunications.com | ||
Investor Relations | ||||
Matt Beck, The Trout Group | +1 (917) 415 1750 (Mobile) | mbeck@troutgroup.com | ||
David Dible, |
Lesen Sie auch
Aktuelle Themen
1 im Artikel enthaltener WertIm Artikel enthaltene Werte